326 related articles for article (PubMed ID: 11838496)
1. The ethics of clinical trials: to inform or not inform? That is the question.
Spence EH
Prof Ethics; 1998; 6(3-4):173-84. PubMed ID: 11838496
[No Abstract] [Full Text] [Related]
2. Bioethical malpractice: risk and responsibilities in human research.
Noah BA
J Health Care Law Policy; 2004; 7(2):175-241. PubMed ID: 15573441
[No Abstract] [Full Text] [Related]
3. Rate of refusal to participate in clinical trials.
Shimm DS; Spece RG
IRB; 1992; 14(2):7-9. PubMed ID: 11651246
[No Abstract] [Full Text] [Related]
4. Is post-marketing drug follow-up research or advertising?
Weiss GB; Winslade WJ
IRB; 1987; 9(4):10-1. PubMed ID: 11649947
[No Abstract] [Full Text] [Related]
5. Ethics of clinical trials for research ethics boards: proceedings of a national workshop.
National Council on Bioethics in Human Research (Canada)
NCBHR Commun; 1991; 2(2):4-23. PubMed ID: 11659919
[No Abstract] [Full Text] [Related]
6. Ethical considerations in informed consent for potential future use of human tissue samples.
Adams M; Prentice ED; Oki GS
IRB; 1996; 18(2):6-7. PubMed ID: 11654756
[No Abstract] [Full Text] [Related]
7. Parents say federal agency helps protect researchers from more than their subjects.
Maloney DM
Hum Res Rep; 2000 Oct; 15(10):5-6. PubMed ID: 11913435
[No Abstract] [Full Text] [Related]
8. Why I oppose drug company payment of physician/investigators on a per patient/subject basis.
Roizen R
IRB; 1988; 10(1):9-10. PubMed ID: 11658990
[No Abstract] [Full Text] [Related]
9. Conflict of interest in human research ethics.
Jones DJ
NCBHR Commun; 1995; 6(2):5-10. PubMed ID: 11654611
[No Abstract] [Full Text] [Related]
10. Legal and ethical issues associated with patient recruitment in clinical trials: the case of competitive enrolment.
Caulfield T
Health Law Rev; 2005; 13(2-3):58-61. PubMed ID: 16459415
[No Abstract] [Full Text] [Related]
11. Lawsuits target medical research.
Dembner A
IRB; 2002; 24(4):14-5. PubMed ID: 13678031
[No Abstract] [Full Text] [Related]
12. Researchers must inform subjects about financial incentives for study.
Maloney DM
Hum Res Rep; 1999 Aug; 14(8):6. PubMed ID: 11657806
[No Abstract] [Full Text] [Related]
13. Adequate protection for the autonomous research subject? The disclosure of sources of funding and commercialisation in genetic research trials.
Cote A
Manit Law J; 2002; 28(3):347-58. PubMed ID: 15162817
[No Abstract] [Full Text] [Related]
14. Clinical trials and physicians as double agents.
Levine RJ
Yale J Biol Med; 1992; 65(2):65-74. PubMed ID: 1519378
[TBL] [Abstract][Full Text] [Related]
15. Conflict of interest and informed consent in industry-sponsored clinical trials.
Shimm DS; Spece RG
J Leg Med; 1991 Dec; 12(4):477-513. PubMed ID: 1800586
[No Abstract] [Full Text] [Related]
16. Conflict + interest: financial incentives and informed consent in human subject research.
Benbow S
Notre Dame J Law Ethics Public Policy; 2003; 17(1):181-215. PubMed ID: 14986653
[No Abstract] [Full Text] [Related]
17. Recurrent issues in the review of medical research on human subjects.
Moore DL
Albany Law J Sci Technol; 1991; 1():1-33. PubMed ID: 16296123
[No Abstract] [Full Text] [Related]
18. How many subjects are required for a study?
McLarty JW; Levine RJ
IRB; 1987; 9(5):1-3. PubMed ID: 11649896
[No Abstract] [Full Text] [Related]
19. Moore v. Regents of the University of California: expanded disclosure, limited property rights.
Potts J
Northwest Univ Law Rev; 1992; 86(2):453-96. PubMed ID: 11659500
[No Abstract] [Full Text] [Related]
20. Ten questions institutional review boards should ask when reviewing international clinical research protocols.
Fitzgerald DW; Wasunna A; Pape JW
IRB; 2003; 25(2):14-8. PubMed ID: 12833903
[No Abstract] [Full Text] [Related]
[Next] [New Search]
